首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1908017

碎片分析市場：按技術、產品/服務、碎片類型、應用、最終用戶和地區分類

Fragment Analysis Market, By Technology, By Product and Service, By Fragment Type, By Application, By End User, By Geography

出版日期: 2025年12月05日 | 出版商:

Coherent Market Insights | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年碎片分析市場規模預計為 2.813 億美元，預計到 2032 年將達到 5.412 億美元，2025 年至 2032 年的複合年成長率為 9.8%。

報告內容		報告詳情
基準年：	2024	2025年市場規模：	2.813億美元
歷史數據時期：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	9.80%	2032 年的預測值：	5.412億美元

片段分析是一種先進的分子生物學技術，它能夠根據DNA和RNA片段的大小和分子特性，對其進行精確的分離、鑑定和定量。這種分析方法在基因組學、蛋白質組學、法醫學、臨床診斷和藥物研發等多個科學領域都至關重要。全球片段分析市場涵蓋了各種儀器、試劑、耗材和軟體解決方案，能夠以極高的準確性和效率實現高解析度的基因分析。

片段分析技術利用毛細管電泳、自動化定序平台和先進的檢測系統，為研究人員和臨床醫生提供詳細的分子訊息，這些資訊對於微衛星分析、雜合性缺失研究、比較基因組雜合反應和單核苷酸多態性檢測等應用至關重要。受個人化醫療需求不斷成長、癌症研究應用日益廣泛、遺傳疾病患病率上升以及分析儀器技術的持續進步等因素的推動，該市場正經歷顯著成長。隨著全球醫療保健系統將精準醫療和標靶治療方法列為優先事項，片段分析已成為理解基因變異、識別疾病生物標記和開發新型治療性介入的關鍵平台技術，預計將在各種研發和臨床環境中持續擴展。

市場動態

全球片段分析市場受多種強勁促進因素的推動，這些因素持續塑造其成長軌跡，並拓展其在多個領域的應用範圍。其中一個關鍵促進因素源於基因組研究和個人化醫療舉措的指數級成長，片段分析在識別基因變異、突變和多態性方面發揮關鍵作用，而這些對於制定標靶治療策略和診斷通訊協定至關重要。全球遺傳疾病和癌症的日益普及顯著推動了對精準分子診斷工具的需求，而片段分析能夠為研究人員和臨床醫生提供複雜基因研究和臨床決策所需的精確度和解析度。

毛細管電泳系統、自動化平台和高通量定序技術的進步提高了片段分析程序的效率、速度和成本效益，使這些解決方案更容易被研究機構、臨床檢查室和製藥公司所採用。

然而，該市場也面臨諸多限制，包括先進碎片分析設備所需的大量初始投資、需要專門技術知識的複雜操作要求，以及可能延遲新產品核可和市場准入的嚴格監管合規標準。

此外，替代分析方法的激增和新興定序技術的競爭也為市場擴張帶來了挑戰。儘管有這些限制，但仍存在巨大的機遇，包括新興國家對片段分析的日益普及、農業基因組學和環境監測領域應用範圍的擴大、政府對基因組研究項目的資助增加，以及攜帶式、易於使用的儀器的開發，使得先進的分子分析能力能夠在各種實驗室環境和地區廣泛應用。

本次調查的主要特點

本報告以 2024 年為基準年，對全球碎片分析市場進行了詳細分析，並給出了預測期（2025-2032 年）內的市場規模和複合年成長率（%）。
它還重點介紹了不同細分市場的潛在商機，並概述了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
該報告根據以下參數對全球碎片分析市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
這份全球碎片分析市場報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過用於分析全球碎片分析市場的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Thermo Fisher Scientific Inc.
Danaher Corporation
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
QIAGEN NV
Promega Corporation
PerkinElmer Inc.（Revvity）
Merck KGaA（MilliporeSigma）
Hoffmann-La Roche Ltd.
Illumina Inc.
Abbott Laboratories
New England Biolabs Inc.
Takara Bio Inc.
SCIEX
LGC Group

第11章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9028

Fragment Analysis Market is estimated to be valued at USD 281.3 Mn in 2025 and is expected to reach USD 541.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 281.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.80%	2032 Value Projection:	USD 541.2 Mn

Fragment analysis represents a sophisticated molecular biology technique that enables precise separation, identification, and quantification of DNA and RNA fragments based on their size and molecular characteristics. This analytical method has become indispensable in various scientific disciplines, including genomics, proteomics, forensics, clinical diagnostics, and pharmaceutical research. The global fragment analysis market encompasses a comprehensive range of instruments, reagents, consumables, and software solutions designed to facilitate high-resolution genetic analysis with exceptional accuracy and efficiency.

Fragment analysis technologies utilize capillary electrophoresis, automated sequencing platforms, and advanced detection systems to provide researchers and clinicians with detailed molecular insights essential for applications such as microsatellite analysis, loss of heterozygosity studies, comparative genomic hybridization, and single nucleotide polymorphism detection. The market has witnessed substantial growth driven by increasing demand for personalized medicine, expanding applications in cancer research, rising prevalence of genetic disorders, and continuous technological advancements in analytical instrumentation. As healthcare systems worldwide prioritize precision medicine and targeted therapeutic approaches, fragment analysis has emerged as a critical enabler for understanding genetic variations, identifying disease biomarkers, and developing novel therapeutic interventions, positioning this market for sustained expansion across diverse research and clinical environments.

Market Dynamics

The global fragment analysis market is propelled by several compelling drivers that continue to shape its growth trajectory and expand its applications across multiple sectors. The primary driver stems from the exponential growth in genomics research and personalized medicine initiatives, where fragment analysis plays a crucial role in identifying genetic variations, mutations, and polymorphisms essential for developing targeted therapeutic strategies and diagnostic protocols. The increasing prevalence of genetic disorders and cancer worldwide has significantly amplified the demand for precise molecular diagnostic tools, with fragment analysis providing researchers and clinicians with the accuracy and resolution required for complex genetic studies and clinical decision-making.

Technological advancements in capillary electrophoresis systems, automated platforms, and high-throughput sequencing technologies have enhanced the efficiency, speed, and cost-effectiveness of fragment analysis procedures, making these solutions more accessible to research institutions, clinical laboratories, and pharmaceutical companies.

However, the market faces notable restraints including high initial capital investments required for advanced fragment analysis instruments, complex operational requirements demanding specialized technical expertise, and stringent regulatory compliance standards that can delay product approvals and market entry for new technologies.

Additionally, the availability of alternative analytical methods and competition from emerging sequencing technologies pose challenges to market expansion. Despite these constraints, significant opportunities exist in the growing adoption of fragment analysis in emerging economies, expanding applications in agricultural genomics and environmental monitoring, increasing government funding for genomics research programs, and the development of portable, user-friendly instruments that can democratize access to sophisticated molecular analysis capabilities across diverse laboratory settings and geographical regions.

Key Features of the Study

This report provides in-depth analysis of the global fragment analysis market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fragment analysis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, PerkinElmer Inc. (Revvity), Merck KGaA (MilliporeSigma), F. Hoffmann-La Roche Ltd., Illumina Inc., Abbott Laboratories, New England Biolabs Inc., Takara Bio Inc., SCIEX, and LGC Group
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global fragment analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fragment analysis market

Market Segmentation

Technology Insights (Revenue, USD Mn, 2020 - 2032)
- Polymerase Chain Reaction (PCR)-Based Fragment Analysis
- Capillary Electrophoresis (CE)
- Next-Generation Sequencing (NGS)-Based Fragment Analysis
- Microfluidics and Lab-on-Chip Fragment Analysis
- Gel Electrophoresis (Agarose/Polyacrylamide)
Product and Service Insights (Revenue, USD Mn, 2020 - 2032)
- Instruments
- Genetic Analyzers/Sequencers
- PCR Systems
- Microarray Scanners
- Other Instruments
- Consumables and Reagents
- Kits and Assays
- Enzymes and Master Mixes
- Standards and Size Markers
- Other Reagents
- Software and Services
Fragment Type Insights (Revenue, USD Mn, 2020 - 2032)
- DNA Fragments
- RNA Fragments
- Protein Fragments (Low-use, niche applications)
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Nucleic Acid Analysis
- Genotyping (SSR, SNP)
- Mutation Detection and Sequencing
- Others (Microsatellite Instability Analysis, etc.)
- Quality Control and Validation
- Next-Generation Sequencing Library QC
- CRISPR Edit Confirmation
- Others (PCR Product Verification, etc.)
- Genetic Fingerprinting and Forensics
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Clinical Diagnostics Laboratories
- Hospitals
- Research and Academic Institutes
- Biopharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Promega Corporation
- PerkinElmer Inc. (Revvity)
- Merck KGaA (MilliporeSigma)
- Hoffmann-La Roche Ltd.
- Illumina Inc.
- Abbott Laboratories
- New England Biolabs Inc.
- Takara Bio Inc.
- SCIEX
- LGC Group

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Fragment Analysis Market, By Technology
- Global Fragment Analysis Market, By Product and Service
- Global Fragment Analysis Market, By Fragment Type
- Global Fragment Analysis Market, By Application
- Global Fragment Analysis Market, By End User
- Global Fragment Analysis Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Fragment Analysis Market, By Technology, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Polymerase Chain Reaction (PCR)-Based Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Capillary Electrophoresis (CE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Next-Generation Sequencing (NGS)-Based Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Microfluidics and Lab-on-Chip Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Gel Electrophoresis (Agarose/Polyacrylamide)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Fragment Analysis Market, By Product and Service, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  - Genetic Analyzers/Sequencers
  - PCR Systems
  - Microarray Scanners
  - Other Instruments
Consumables and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  - Kits and Assays
  - Enzymes and Master Mixes
  - Standards and Size Markers
  - Other Reagents
Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Fragment Analysis Market, By Fragment Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
DNA Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
RNA Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Protein Fragments (Low-use, niche applications)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Fragment Analysis Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Nucleic Acid Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  - Genotyping (SSR, SNP)
  - Mutation Detection and Sequencing
  - Others (Microsatellite Instability Analysis, etc.)
Quality Control and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  - Next-Generation Sequencing Library QC
  - CRISPR Edit Confirmation
  - Others (PCR Product Verification, etc.)
Genetic Fingerprinting and Forensics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Fragment Analysis Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Clinical Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Biopharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Fragment Analysis Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer Inc. (Revvity)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA (MilliporeSigma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
New England Biolabs Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SCIEX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LGC Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies